Michael Asger Andersen1,2, Rebecca Valentin1,3, Lene Dissing Sjö4, Line Borgwardt5, Kjeld Schmiegelow6,7, Mette Klarskov Andersen4,8, Rasmus L Marvig5, Christina Westmose Yde5, Carsten Utoft Niemann1. 1. Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. 2. Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark. 3. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. 4. Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. 5. Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. 6. Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Copenhagen, Denmark. 7. Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark. 8. Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Authors: Paul J Hampel; Sameer A Parikh; Timothy G Call; Mithun V Shah; N Nora Bennani; Aref Al-Kali; Kari G Rabe; Yucai Wang; Eli Muchtar; Jose F Leis; Saad S Kenderian; Amber B Koehler; Susan M Schwager; Susan L Slager; Neil E Kay; Curtis A Hanson; Daniel L Van Dyke; Min Shi; Wei Ding Journal: Blood Cancer J Date: 2021-03-02 Impact factor: 11.037